← Back to Search

Other

Blood Flow Restriction Training for Vascular Health

N/A

Recruiting

Led By Hirofumi Tanaka, PhD

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline measurement and measurement at 2 weeks

Awards & highlights

Study Summary

This trialinvestigates how different types of Blood Flow Restriction (BFR) resistance training affects vascular health, and if one type improves vascular health better than the other. Both types are equally effective at increasing muscle strength.

Who is the study for?

This trial is for healthy, sedentary or recreationally active young adults aged 18-40 who have agreed to participate. It's not suitable for those on cardiovascular medications, with morbid obesity, current smokers, people with hypertension or overt cardiovascular disease, anyone currently doing resistance training, or those diagnosed with COVID-19.Check my eligibility

What is being tested?

The study is examining how blood flow restriction (BFR) resistance training affects vascular function in participants. Two types of BFR devices are being compared: wide-rigid cuffs and narrow elastic bands. The hypothesis suggests that while both may increase muscle strength, the effects on vascular health could differ.See study design

What are the potential side effects?

Potential side effects might include minor and reversible impacts on vascular function from using wide-rigid cuffs for BFR training. Narrow elastic bands may improve vascular function but specific side effect profiles are not detailed.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline measurement and measurement at 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline measurement and measurement at 2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline measurement and measurement at 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline grip strength at 2 weeks

Change from baseline muscle strength at 2 weeks

Change from baseline vascular function at 2 weeks

Secondary outcome measures

Blood flow responses to different types of cuff

Change from baseline arterial stiffness at 2 weeks

Change from baseline blood lactate concentration

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Wide-rigid cuffExperimental Treatment1 Intervention

The wide-rigid cuff will be randomly assigned to one of the subject's arms.

Group II: Narrow-elastic bandExperimental Treatment1 Intervention

The narrow-elastic band will be randomly assigned to another arm of the subject.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Blood flow restriction resistance training

2020

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor

350 Previous Clinical Trials

80,959 Total Patients Enrolled

Hirofumi Tanaka, PhDPrincipal InvestigatorThe University of Texas at Austin

3 Previous Clinical Trials

109 Total Patients Enrolled

Media Library

Blood flow restriction resistance training (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05451641 — N/A

Flow-mediated Dilatation Research Study Groups: Wide-rigid cuff, Narrow-elastic band

Flow-mediated Dilatation Clinical Trial 2023: Blood flow restriction resistance training Highlights & Side Effects. Trial Name: NCT05451641 — N/A

Blood flow restriction resistance training (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05451641 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment include elderly participants?

"According to the conditions of this clinical trial, only participants between 18 and 40 years old are permitted."

Answered by AI

What are the key aims of this clinical trial?

"This medical trial seeks to assess the Change from baseline grip strength of participants over a two-week period as its primary endpoint. Secondary endpoints consist of assessing Changes from baseline blood pressure with an Omron digital monitor, fat mass via bioelectrical impedance analysis, and heart rate through a heart rate monitor during all training sessions."

Answered by AI

Are there still available slots for participants of this research endeavor?

"Confirmed. The details on clinicaltrials.gov suggest this medical trial is still enlisting participants, which began being sought out after its initial post date of September 20th 2022 and most recent update on October 31st 2022. Only 25 patients are required at a single centre for the study to be complete."

Answered by AI

Is it possible for me to become a participant in this clinical experiment?

"For consideration in this clinical trial, applicants must meet the criteria of both flow-mediated vasodilatation (fmd) and an age range between 18 and 40. The study is searching for a total of 25 suitable candidates."

Answered by AI

What is the current enrollment of this research endeavor?

"Affirmative. According to records hosted on clinicaltrials.gov, this medical research has been open for recruitment since September 20th 2022 and was modified lastly on October 31st 2022. The project is searching for 25 individuals at 1 trial site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Blood Flow Restriction Resistance Training Intervention on Vascular Function

2022. "Blood Flow Restriction Resistance Training Intervention on Vascular Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05451641.